NasdaqCM - Nasdaq Real Time Price USD

PolyPid Ltd. (PYPD)

3.4100
-0.0200
(-0.58%)
At close: June 13 at 4:00:01 PM EDT
3.3501
-0.06
(-1.76%)
After hours: June 13 at 7:58:20 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for PYPD

Recent News: PYPD

View More
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial

Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
Benzinga 6 days ago
PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints

PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints
GlobeNewswire 6 days ago
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
GlobeNewswire 9 days ago
Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls

Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls
TipRanks 9 days ago
PYPD: Assessing & Advancing Lead Candidate D-PLEX₁₀₀, Through Clinical Trials to Improve Surgical Outcomes, Enhance Treatment Efficacy, Minimize Side Effects

PYPD: Assessing & Advancing Lead Candidate D-PLEX₁₀₀, Through Clinical Trials to Improve Surgical Outcomes, Enhance Treatment Efficacy, Minimize Side Effects
Zacks Small Cap Research 13 days ago
PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire 26 days ago

PolyPid Ltd (PYPD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus.com last month
PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results

PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire last month
PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025

PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025
GlobeNewswire last month
PolyPid to Participate in The Citizens Life Sciences Conference

PolyPid to Participate in The Citizens Life Sciences Conference
GlobeNewswire last month
Q1 Virtual Investor Summit: On-Demand Presentations Now Live

Q1 Virtual Investor Summit: On-Demand Presentations Now Live
ACCESS Newswire 2 months ago
View More

Related Tickers

ELAB PMGC Holdings Inc.
2.0800
-4.15%
 
WINT Windtree Therapeutics, Inc.
0.5920
-1.99%
 
TPST Tempest Therapeutics, Inc.
6.61
-7.03%
 
EVGN Evogene Ltd.
1.3800
-9.21%
 
SNPX Synaptogenix, Inc.
3.7100
-23.66%
 
MGNX MacroGenics, Inc.
1.5200
-1.94%
 
KZIA Kazia Therapeutics Limited
9.30
-5.01%
 
PLRZ Polyrizon Ltd.
0.8350
-21.96%
 
UNCY Unicycive Therapeutics, Inc.
0.6814
+6.82%
 
LIMN Liminatus Pharma, Inc.
14.42
-29.00%